We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ERS Genomics, Evolva Signs License Agreement

News   Oct 28, 2016

 
ERS Genomics, Evolva Signs License Agreement
 
 
Advertisement
 

RELATED ARTICLES

Recreating Nature: Chemists Create Synthetic Version of Natural Anti-Cancer Agent

News

Scripps Research chemists Hans Renata, PhD, and Alexander Adibekian, PhD, have discovered a way to efficiently create a synthetic version of a valuable natural compound called cepafungin I, which has shown promise as an anti-cancer agent.

READ MORE

Two Is Better Than One for Novel COVID-19 Mouse Model

News

Researchers have developed a new mouse model to study SARS-CoV-2 infection and disease and to accelerate testing of novel treatments and vaccines against the novel coronavirus.

READ MORE

Scientists Visualize the Largest and Most Complex CRISPR System

News

Now researchers from the University of Copenhagen (UCPH) have mapped and analysed the atomic structure of one of the most complex CRISPR systems so far.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE